SCHEMBL10183922

SCHEMBL10183922

O=C1C(N(C(=O)Cc2c[nH]c3cnccc23)c2cccc(F)c2)c2ccccc2N1C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 1/20 0.36
▸ DRD2 P14416 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ MAPT P10636 3/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD11B1 P28845 1/20 0.33
▸ MC4R P32245 1/20 0.33
▸ MC5R P33032 1/20 0.33
▸ MC3R P41968 1/20 0.33
▸ USP2 O75604 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ OPRM1 P35372 3/20 0.32
▸ OPRK1 P41145 3/20 0.32
▸ OPRL1 P41146 3/20 0.32
▸ POLB P06746 1/20 0.31
▸ IDH1 O75874 1/20 0.31
▸ SSTR3 P32745 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183227 0.91 MAPT (0.42) HTR1ADRD2HTR2AMAPTMEN1
SCHEMBL10185957 0.83 TSHR (0.43) MAPTKMT2AUSP2KDM4ETSHR
SCHEMBL10185553 0.82 CYP3A4 (0.34) HTR1ADRD2HTR2AMAPTMEN1
SCHEMBL10184008 0.80 PTGIR (0.38) MAPTUSP2KDM4ETSHROPRM1
SCHEMBL10183299 0.79 OPRM1 (0.40) MAPTOPRM1OPRK1OPRL1IDH1
SCHEMBL10183319 0.79 MEN1 (0.43) MAPTMEN1KMT2AKDM4EOPRM1
SCHEMBL10183337 0.79 OPRM1 (0.39) MAPTMEN1KMT2AOPRM1OPRK1
SCHEMBL10185857 0.78 SLC6A2 (0.38) MAPTKDM4EOPRM1OPRK1OPRL1
SCHEMBL10183925 0.78 TP53 (0.41) MAPTMEN1KMT2AKDM4ETSHR
SCHEMBL10183321 0.78 OPRM1 (0.37) MAPTMEN1KMT2AOPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback